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Dear Editor, 
 
Cancer is a leading cause of death worldwide accounting for 15 % of all deaths. Breast 
cancer has been found to be the most common malignancy in females accounting for 36.9 % 
of the total female cancers in West Algeria (Benarba et al., 2014). In recent years, a high 
prevalence of the use of alternative medicine and especially medicinal plants among cancer 
patients has been documented (Tazi et al., 2013). No study has been published previously re-
garding the use of medicinal plants by Algerian cancer patients. The present study aimed to 
assess and document the use of medicinal plants among breast cancer patients living in North 
West Algeria. 
Of one hundred fifty patients invited to participate in the present study, sixty nine gave 
available data about use of medicinal plants. All of them were women, and their mean age 
was 47 years (age: 47.49 ± 11.07 years). Interestingly, forty-three patients (62 %) were aged 
20 - 49 years. Most (81 %) of the population study were married. Regarding intellectual level, 
twenty nine patients (42 %) were illiterate, twenty four (35 %) followed secondary or higher 
education, and fourteen (20 %) had primary education level. Of the interviewed patients, fifty 
five (72.7 %) were housewives and stated that they exercised no professional activity even at 
home (being housewife in Algeria does not mean being without occupation), and fourteen 
(20.2 %) were professionals (administration, education and nursing).  
Regarding use of medicinal plants, 43.4 % of breast cancer patients enrolled in the present 
study used medicinal plants alone or mixed with other plants and/or non-plants-products. 
Fourteen of them reported having had a beneficial effect of the use of plants during their ill-
ness, against twelve who have felt no effect. In addition, three of them have experienced side 
effects including diarrhea, nausea and in one case, kidney problems. Two patients used vege-
tal formulation of unknown plants, bought from Oman (Middle East country). These formula-
tions are purchased at prices ranging from 200 - 500 euro through an Arabic TV channel pro-
moting alternative medicine services and products. Two other patients used similar local for-
mulations. The reported plants are given in Table 1.  
We found that Aristolochia longa L. was the most frequently used by breast cancer pa-
tients (31.9 %), followed by Berberis vulgaris L. (27.6 %) and Atriplex halimus (14.9 %). It is 
the first time that Berberis vulgaris L. and Atriplex halimus are reported to be used to treat 
cancer in North Africa. Most of cited species (except A. longa and A. halimus) are used as 
mixtures. Honey remains the preferred adjuvant added to different plant species. Addition of 
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honey aims to improve the acceptability of certain plants having a bitter taste unbearable such 
as Aristolochia longa L.  
We must emphasize that Aristolochia longa is a toxic plant, due to the presence of aris-
tolochic acids. In a recent study, we have reported that in postmenopausal women newly di-
agnosed for breast cancer, the intake of A. longa roots resulted in renal function problems and 
high bone resorption, maybe due to the reduction in renal function caused by the aristolochic 
acids contained in the roots (Benarba et al., 2012). We have demonstrated the anticancer ac-
tivity of an aqueous extract of A. longa roots against breast cancer HBL-100 and MDA-MB-
231 cell lines (data not published). Interestingly, the extract (free of aristolochic acids) was 
safe when administered orally in Wistar rats in a single dose.  
Our study highlights the fact that about half of Algerian breast cancer patients use medici-
nal plants for “treating” their illness, and that studying the effectiveness and the side effects of 
such “traditions” should be carried out, urgently. The integration of medicinal plants with 
conventional therapy of breast cancer could be of great importance in terms of healing. Never-
theless, extensive studies on their effectiveness are essential before use. 
 
Table 1: Medicinal plants used by breast cancer patients 
 
Botanical name 
Family Part used 
Preparation 
method Administration 
Use reports 
(%) 
Berberis vulgaris L. 
Berberidaceae Roots Raw Oral 13 (27.6%) 
Aristolochia longa L. 
Aristolochiaceae Roots Raw Oral 15 (31.9%) 
Prunus persica (L.) Batsch 
Rosaceae Leaves Raw Oral 2 (04.2%) 
Atriplex halimus  
Chenopodiaceae Seeds Decoction Oral 7 (14.9%) 
Glycyrrhiza glabra L. 
Papilionaceae/ Fabaceae Roots Infusion Oral 1 (02.1%) 
Nigella sativa L. 
Ranunculaceae seeds Paste Oral 4 (08.5%) 
Pimpinella anisum L. 
Apiaceae seeds Infusion Oral 2 (04.2%) 
Allium sativum L. 
Liliaceae Bulb Raw Oral 1 (02.1%) 
Thymus vulgaris L. 
Lamiaceae Aerial parts Infusion Oral 1 (02.1%) 
Artemisia herba-alba L. 
Asteraceae Aerial parts Decoction Oral 1 (02.1%) 
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